Cambridge Healthtech Institute’s 14th Annual

Advancing Novel Frameworks for Companion Diagnostics

Global View of the Evolving Landscape

August 21-22, 2023

Development of companion diagnostics shows no signs of slowing down anytime soon. As the field continues to grow, it is critical that the surrounding landscape progresses with it. Partnerships between pharmaceutical and diagnostic companies can lead to higher quality of care and better patient outcomes as medicine becomes increasingly personalized. Novel development pathways and evolving regulatory requirements play a key role in the direction that pharmaceutical and diagnostics companies take as well. Cambridge Healthtech Institute's 14th annual Advancing Novel Frameworks for Companion Diagnostics conference seeks to bring clarity to these issues at the forefront, facilitate collaboration between pharmaceutical and diagnostics companies, and examine areas where opinions differ and converge between executives, business experts, regulators, scientists, clinicians, and other parties involved in companion diagnostics, drug-diagnostics co-development, and precision medicine.

Coverage will include, but is not limited to:

Reviewing regulatory strategies for companion diagnostic approval
Clarifying and implementing policy updates
Examining global considerations for companion diagnostics
Exploring alternative development pathways for companion diagnostics
Assessing viability of minimum performance standards for diagnostics
Maximizing marketability of diagnostics
Establishing avenues for efficiency and scalability of diagnostic development

The deadline for priority consideration is January 30, 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: